Literature DB >> 15793122

Compensatory adaptation to the loss of biological fitness associated with acquisition of fusidic acid resistance in Staphylococcus aureus.

Silke Besier1, Albrecht Ludwig, Volker Brade, Thomas A Wichelhaus.   

Abstract

Recent studies have shown that individual amino acid exchanges within elongation factor G (EF-G) cause fusidic acid resistance in Staphylococcus aureus. The data from the present study illustrate that the fusidic acid resistance-mediating amino acid substitutions P406L and H457Y are associated with a marked impairment of the biological fitness of S. aureus. In particular, strains producing EF-G derivatives with these mutations showed reduced growth, decreased plasma coagulase activity, and an impaired capability to compete with the isogenic wild-type strain. Second-site mutations within EF-G, such as A67T and S416F, that have been encountered in clinical fusidic acid-resistant isolates containing the amino acid exchanges P406L and H457Y, respectively, were shown not to contribute to resistance. Furthermore, the substitution A67T had no impact on the biological fitness in vitro. The exchange S416F, however, was found to function as a fitness-compensating mutation in S. aureus carrying the substitution H457Y in EF-G. In conclusion, the data presented in this report provide evidence at the molecular level that the deleterious effects of fusidic acid resistance-mediating exchanges within EF-G of S. aureus can be reduced considerably by specific compensating mutations in this target protein. This compensatory adaptation most likely plays a significant role in the stabilization of resistant bacteria within a given population.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15793122      PMCID: PMC1068613          DOI: 10.1128/AAC.49.4.1426-1431.2005

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  28 in total

1.  Effects of environment on compensatory mutations to ameliorate costs of antibiotic resistance.

Authors:  J Björkman; I Nagaev; O G Berg; D Hughes; D I Andersson
Journal:  Science       Date:  2000-02-25       Impact factor: 47.728

2.  Compensatory adaptation to the deleterious effect of antibiotic resistance in Salmonella typhimurium.

Authors:  Sophie Maisnier-Patin; Otto G Berg; Lars Liljas; Dan I Andersson
Journal:  Mol Microbiol       Date:  2002-10       Impact factor: 3.501

Review 3.  Persistence of antibiotic resistant bacteria.

Authors:  Dan I Andersson
Journal:  Curr Opin Microbiol       Date:  2003-10       Impact factor: 7.934

4.  Emergence of a new community acquired MRSA strain in Germany.

Authors:  W Witte; C Cuny; B Strommenger; C Braulke; D Heuck
Journal:  Euro Surveill       Date:  2004-01

5.  Fucidin: a new orally active antibiotic.

Authors:  W GODTFREDSEN; K ROHOLT; L TYBRING
Journal:  Lancet       Date:  1962-05-05       Impact factor: 79.321

6.  Formation of the ribosome-G factor-GDP complex in the presence of fusidic acid.

Authors:  J W Bodley; F J Zieve; L Lin; S T Zieve
Journal:  Biochem Biophys Res Commun       Date:  1969-10-22       Impact factor: 3.575

7.  Biological cost of rifampin resistance from the perspective of Staphylococcus aureus.

Authors:  Thomas A Wichelhaus; Boris Böddinghaus; Silke Besier; Volker Schäfer; Volker Brade; Albrecht Ludwig
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

8.  Genetic characterization of the fusidic acid and cadmium resistance determinants of Staphylococcus aureus plasmid pUB101.

Authors:  Frances G O'Brien; Christopher Price; Warren B Grubb; John E Gustafson
Journal:  J Antimicrob Chemother       Date:  2002-09       Impact factor: 5.790

9.  Fusidic acid-resistant mutants of Salmonella enterica serovar Typhimurium with low fitness in vivo are defective in RpoS induction.

Authors:  Mirjana Macvanin; Johanna Björkman; Sofia Eriksson; Mikael Rhen; Dan I Andersson; Diarmaid Hughes
Journal:  Antimicrob Agents Chemother       Date:  2003-12       Impact factor: 5.191

10.  Molecular analysis of fusidic acid resistance in Staphylococcus aureus.

Authors:  Silke Besier; Albrecht Ludwig; Volker Brade; Thomas A Wichelhaus
Journal:  Mol Microbiol       Date:  2003-01       Impact factor: 3.501

View more
  20 in total

1.  Linezolid resistance in Staphylococcus aureus: gene dosage effect, stability, fitness costs, and cross-resistances.

Authors:  Silke Besier; Albrecht Ludwig; Johannes Zander; Volker Brade; Thomas A Wichelhaus
Journal:  Antimicrob Agents Chemother       Date:  2008-01-22       Impact factor: 5.191

2.  Compensation of fitness costs and reversibility of antibiotic resistance mutations.

Authors:  Pia Schulz zur Wiesch; Jan Engelstädter; Sebastian Bonhoeffer
Journal:  Antimicrob Agents Chemother       Date:  2010-02-22       Impact factor: 5.191

Review 3.  Antibiotic resistance and its cost: is it possible to reverse resistance?

Authors:  Dan I Andersson; Diarmaid Hughes
Journal:  Nat Rev Microbiol       Date:  2010-03-08       Impact factor: 60.633

Review 4.  Current and Emerging Topical Antibacterials and Antiseptics: Agents, Action, and Resistance Patterns.

Authors:  Deborah A Williamson; Glen P Carter; Benjamin P Howden
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

Review 5.  Fusidic Acid: A Bacterial Elongation Factor Inhibitor for the Oral Treatment of Acute and Chronic Staphylococcal Infections.

Authors:  Prabhavathi Fernandes
Journal:  Cold Spring Harb Perspect Med       Date:  2016-01-04       Impact factor: 6.915

Review 6.  Understanding the rise of the superbug: investigation of the evolution and genomic variation of Staphylococcus aureus.

Authors:  Jodi A Lindsay; Matthew T G Holden
Journal:  Funct Integr Genomics       Date:  2006-02-02       Impact factor: 3.410

7.  Fusidic acid resistance determinants in Staphylococcus aureus clinical isolates.

Authors:  Hsiao-Jan Chen; Wei-Chun Hung; Sung-Pin Tseng; Jui-Chang Tsai; Po-Ren Hsueh; Lee-Jene Teng
Journal:  Antimicrob Agents Chemother       Date:  2010-09-20       Impact factor: 5.191

8.  Performance of fusidic acid (CEM-102) susceptibility testing reagents: broth microdilution, disk diffusion, and Etest methods as applied to Staphylococcus aureus.

Authors:  Ronald N Jones; Mariana Castanheira; Paul R Rhomberg; Leah N Woosley; Michael A Pfaller
Journal:  J Clin Microbiol       Date:  2010-01-06       Impact factor: 5.948

9.  The fusidic acid stimulon of Staphylococcus aureus.

Authors:  Alejandro Delgado; Shahrear Zaman; Arunachalam Muthaiyan; Vijayaraj Nagarajan; Mohamed O Elasri; Brian J Wilkinson; John E Gustafson
Journal:  J Antimicrob Chemother       Date:  2008-09-10       Impact factor: 5.790

10.  A fitness cost associated with the antibiotic resistance enzyme SME-1 beta-lactamase.

Authors:  David C Marciano; Omid Y Karkouti; Timothy Palzkill
Journal:  Genetics       Date:  2007-06-11       Impact factor: 4.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.